Development of a SARS‐CoV‐2 neutralization assay based on a pseudotyped virus using a HIV system

Documenti analoghi

• Optimization and validation of a virus‐like particle pseudotyped virus neutralization assay for SARS‐CoV‐2
  di: Shuo Liu, et al.
  Pubblicazione: (2024)
• A Pseudovirus‐Based Method for the Simultaneous Quantitation of Neutralization Antibodies Against All Three Poliovirus Serotypes
  di: Meiyan Liu, et al.
  Pubblicazione: (2025)
• Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue
  di: Qianqian Li, et al.
  Pubblicazione: (2024)
• Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variants
  di: Ying Lu, et al.
  Pubblicazione: (2025)
• SARS‐CoV‐2 Spike Protein as a Target of the COVID‐19 Vaccine Disrupts Insulin Signaling in Type 2 Diabetes
  di: Lixiang Zhai, et al.
  Pubblicazione: (2025)